Lipoprotein(a) and Cardiovascular Disease | G...

Cell and gene therapy has entered a new phase. The science is advancing rapidly, but the harder question is increasingly becoming: How do we actually get these therapies to the right patient, at the right treatment center, with the financing, logistics, clinical support, and foll ...  Show more

A patient's copay unexpectedly jumped to nearly $500. Upon investigation, it was discovered his plan design had changed, penalizing him for using our pharmacy. He was now facing higher costs or needing to switch to a chain or mail-order pharmacy. 

In this podcast, Dr Emma Nash talks to Professor Derek Connolly about cardiovascular disease and lipid management. Measuring and interpreting lipid profiles and when to initiate treatment are discussed. Professor Connolly takes us through the various treatment options and their r ...  Show more

What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a). Learn how to interpret results, counsel patients, and navigate topics with limi ...  Show more

Drs Larry Sperling and Karol Watson discuss health equity and social determinants of health for populations with dyslipidemia. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958746). The topics and discussions a ...  Show more

View the Show Notes Page for ...